Skip to main content
. 2013 Oct;10(5):432–440. doi: 10.1513/AnnalsATS.201304-097OC

Figure 1.

Figure 1.

(A) Pneumonia syndrome incidence during induction chemotherapy in patients with acute leukemia. (B) Hazard function by type of leukemia. There is left and right truncation of the curves because the hazard functions are calculated over the range of observed failure times for each group using a weighted kernel-density estimate. ALL = acute lymphoblastic leukemia; AML = acute myeloid leukemia; MDS = acute myelodysplastic syndrome.